Long-term Use of Immunotherapy May Be Safe for Patients With Alveolar Soft Part Sarcoma
April 18, 2026
April 18, 2026
PHILADELPHIA, Pennsylvania, April 18 [Category: Medical] -- The American Association for Cancer Research posted the following news release:
* * *
Long-term Use of Immunotherapy May Be Safe for Patients With Alveolar Soft Part Sarcoma
*
SAN DIEGO - Long-term adverse events were rare and manageable among patients with alveolar soft part sarcoma (ASPS), which primarily affects adolescents and young adults, who received immunotherapy beyond the sta . . .
* * *
Long-term Use of Immunotherapy May Be Safe for Patients With Alveolar Soft Part Sarcoma
*
SAN DIEGO - Long-term adverse events were rare and manageable among patients with alveolar soft part sarcoma (ASPS), which primarily affects adolescents and young adults, who received immunotherapy beyond the sta . . .